USP51 and triple-negative breast carcinoma: Similarly, in triple-negative breast cancer (TNBC), the stabilization of ABCB1 via USP51-mediated deubiquitination enhances resistance to doxorubicin, while targeting USP51 impairs this resistance (Ou et al., 2024).